Table 2.

Clinical characteristics of the patients enrolled. Patients for whom cell lines were not obtained are reported with gray background.

CRC Line	Age	Sex	Diagnosis	T	N	M	Stage	Treatment	TRG	Mutation Status
										KRAS	NRAS	BRAF
1	60	M	adenocarcinoma	3	2	X	3B	5FU + 50GY RADIO NEOADJ	2	WT	WT	WT
2	50	M	adenocarcinoma	3	0	0	2A	5FU + 50GY RADIO NEOADJ	1	WT	WT	WT
3	46	F	adenocarcinoma	3	1	0	3B	5FU + 50GY RADIO NEOADJ	1	MUT	WT	WT
4	78	F	adenocarcinoma	2	0	0	2	5FU + 50GY RADIO NEOADJ	2	WT	WT	WT
NE1	68	F	adenocarcinoma	3	1	0	3B	5FU + 50GY RADIO NEOADJ	0	WT	WT	WT
NE2	67	F	adenocarcinoma	3	1	0	3B	5FU + 50GY RADIO NEOADJ	0	WT	WT	WT
NE3	61	M	adenocarcinoma	3	1	0	3B	5FU + 50GY RADIO NEOADJ	3	WT	MUT	WT